Fondazione I.r.c.c.s. Istituto Neurologico Carlo Besta
Clinical trials sponsored by Fondazione I.r.c.c.s. Istituto Neurologico Carlo Besta, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Brain surgery sedation: do current dosing models work in the ICU? Results expected Oct 2026 (estimated)
- Brain tumor surgery study aims to map hidden attention deficits Results expected Oct 2026 (estimated)
- Brain wave markers may reveal who benefits from mindfulness for migraine Results expected Oct 2026 (estimated)
- Global data pooling aims to unlock secrets of rare muscle disease Results expected Dec 2026 (estimated)
- Epilepsy surgery study tracks Patients' mental health over time Results expected Dec 2026 (estimated)
-
Home telerehab may keep MS balance gains going after hospital therapy
Symptom relief OngoingThis pilot trial tests whether people with multiple sclerosis can safely and satisfactorily use a telemedicine platform for balance rehabilitation at home. After completing intensive in-hospital rehabilitation, participants either follow a 12-week home telerehabilitation program …
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Nurse-Led video care may ease daily life for rare Parkinson's forms
Symptom relief OngoingThis study tests whether a home-based telenursing program, led by a specialist nurse, can improve quality of life and reduce complications like falls for people with atypical parkinsonism (MSA or PSP). About 164 participants will receive proactive and reactive remote monitoring a…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Brain tumor breakthrough? simple blood test could replace risky biopsies
Knowledge-focused OngoingThis study tests whether a substance called 5-ALA, already used during brain surgery to make tumor cells glow, can also be detected in blood or urine. Researchers hope this 'liquid biopsy' could help diagnose and monitor glioblastoma, the most common and deadly brain tumor, witho…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Blood test may predict brain tumor return
Knowledge-focused OngoingThis study looks at epigenetic changes in meningioma tumors and blood samples to find markers that could predict if the tumor will come back after surgery. Researchers will analyze tissue from past patients and collect blood from new patients. The goal is to improve personalized …
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Sniffing out Parkinson's: new study uses nose, blood, and urine to catch disease early
Knowledge-focused OngoingThis study aims to find early markers of Parkinson's disease, multiple system atrophy, and Lewy body dementia by analyzing samples from the nose, blood, and urine. Researchers will compare results from 180 people with these conditions and healthy volunteers. The goal is to improv…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Scientists hunt for hidden signs of ALS and FTD in skin and tears
Knowledge-focused OngoingThis study aims to find biological markers (biosignatures) in people with ALS and FTD to make diagnosis more precise. Researchers will analyze samples like spinal fluid, skin, and tears from 230 participants using advanced techniques. The goal is to create a 'disease fingerprint'…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Global data pooling aims to unlock secrets of rare muscle disease
Knowledge-focused OngoingThis study brings together patient registries from 10 countries to analyze data from 700 people with spinal and bulbar muscular atrophy (SBMA). Researchers will look at changes in muscle function, walking ability, and age of symptom onset. The goal is to better understand how the…
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC